112
64$*GHULYDWHV
SROĮSRO ȕ
>@
6RODQDS\URQH$
2
2
+
2
0H2
+
+
0H
SROȕSROȜ
>@
640*
2
2
2
+
2
62 +
+
+
+
+
+2
+2
+2
SROȕ
>@
6XOIROLSLGGHULYDWLYH
2
6
2
2
+2
2+
2+
2+
2
2
2
2
SROĮSROȕ
>@
7D[LQLQH
2$F
2$F
E]
$F2
2
SROĮSROȕ
>@
7D[ROHGHULYDWH
2
2
$F2
2
2
2
2$F
2
2+
SROĮ
>@
7RFRWULHQRO
SROȜ
>@
7ULWHUSHQRLGGHULYDWLYH
+2
&22+
SROȕ
>@
Table 4.2 (continued)
Abbreviations: DRB 1,4-dideoxy-1,4-imino-d-ribitol, HCMV human cytomegalovirus, HSV
herpes simplex virus, HMI 4-Hydroxy-17-methylincisterol, KA-A 11 (1S*,4aS*,8aS*)17-(1,4,4a,5,6,7,8,8a-octahydro-2,5,5,8atetramethylnaphthalen-1-yl)heptadecanoic acid,
KAG kaempferol 3-O-(600-acetyl)-b-glucopyranoside, KN-208 1-O-(6′-sulfo-alpha-dglucopyranosyl)-2,3-di-O-phytanyl-sn-glycerol, MK-866 1H-Indole-2-propanoic acid, QAG
quercetin 3-O-(600-acetyl)-b-glucopyranoside, PGG penta-O-galloyl-beta-d-glucose, SQAG
sulfoquinovosyl-acylglycerol, SQMG sulfoquinovosylmonoacylglycerol, VZV varicella zoster
virus
A. Yu. Nyporko
64$*GHULYDWHV
SROĮSRO ȕ
>@
6RODQDS\URQH$
2
2
+
2
0H2
+
+
0H
SROȕSROȜ
>@
640*
2
2
2
+
2
62 +
+
+
+
+
+2
+2
+2
SROȕ
>@
6XOIROLSLGGHULYDWLYH
2
6
2
2
+2
2+
2+
2+
2
2
2
2
SROĮSROȕ
>@
7D[LQLQH
2$F
2$F
E]
$F2
2
SROĮSROȕ
>@
7D[ROHGHULYDWH
2
2
$F2
2
2
2
2$F
2
2+
SROĮ
>@
7RFRWULHQRO
SROȜ
>@
7ULWHUSHQRLGGHULYDWLYH
+2
&22+
SROȕ
>@
Table 4.2 (continued)
Abbreviations: DRB 1,4-dideoxy-1,4-imino-d-ribitol, HCMV human cytomegalovirus, HSV
herpes simplex virus, HMI 4-Hydroxy-17-methylincisterol, KA-A 11 (1S*,4aS*,8aS*)17-(1,4,4a,5,6,7,8,8a-octahydro-2,5,5,8atetramethylnaphthalen-1-yl)heptadecanoic acid,
KAG kaempferol 3-O-(600-acetyl)-b-glucopyranoside, KN-208 1-O-(6′-sulfo-alpha-dglucopyranosyl)-2,3-di-O-phytanyl-sn-glycerol, MK-866 1H-Indole-2-propanoic acid, QAG
quercetin 3-O-(600-acetyl)-b-glucopyranoside, PGG penta-O-galloyl-beta-d-glucose, SQAG
sulfoquinovosyl-acylglycerol, SQMG sulfoquinovosylmonoacylglycerol, VZV varicella zoster
virus
A. Yu. Nyporko